小儿脐下手术骶管右美托咪定疗效与安全性:Meta分析及试验序贯分析
本研究通过Meta分析和试验序贯分析评估小儿脐下手术中骶管右美托咪定作为局麻药佐剂的镇痛疗效与安全性。纳入19项RCT(n=1190),结果显示右美托咪定显著延长镇痛时间(ROM 2.14,95%CI 1.83-2.49,p<0.001),减少镇痛给药次数、对乙酰氨基酚总剂量及苏醒期谵妄风险,不良事件无显著差异。
要点
- 骶管右美托咪定显著延长小儿脐下手术镇痛时间,中位倍数2.14。
- 减少术后镇痛给药次数、对乙酰氨基酚用量及苏醒期谵妄风险。
- 低血压、心动过缓、恶心呕吐、尿潴留及呼吸抑制风险未显著增加。
核心结论
- 小儿脐下手术骶管阻滞中,局麻药加入右美托咪定可显著延长镇痛时间并减少镇痛需求,安全性相似。
- 仍需进一步数据评估神经安全性。
研究设计与样本
- 系统检索10个数据库的随机对照试验(RCT),比较小儿脐下手术骶管阻滞加与不加右美托咪定。
- 采用频率学随机效应Meta分析,连续变量以均值比(ROM)、二分类变量以相对危险度(RR)及95%CI表示。
- 纳入19项RCT,共1190例小儿患者。
主要发现
- 与对照组(平均镇痛时间346分钟)相比,右美托咪定组镇痛时间显著延长(ROM 2.14,95%CI 1.83-2.49,p<0.001;证据等级中等)。
- 试验序贯分析显示主要结局信息量充足。
- 右美托咪定减少镇痛给药次数(低证据等级)、对乙酰氨基酚总剂量(中等证据等级)及苏醒期谵妄风险(中等证据等级)。
- 低血压、心动过缓、术后恶心呕吐、尿潴留及呼吸抑制等不良事件无显著差异。
关键数值与推荐
- 主要结局为镇痛持续时间,定义为从骶管注射至研究特定疼痛评分超过阈值的时间。
- 对照组平均镇痛时间346分钟,右美托咪定组ROM 2.14(95%CI 1.83-2.49,p<0.001)。
- 证据等级:主要结局为中等,镇痛给药次数为低,对乙酰氨基酚剂量及苏醒期谵妄为中等。
临床怎么用
- 小儿脐下手术骶管阻滞时可考虑在局麻药中加入右美托咪定以延长镇痛并减少术后镇痛需求。
- 需监测不良事件,但现有证据未显示低血压、心动过缓、呼吸抑制等风险显著增加。
局限性
- 神经安全性数据不足,需进一步研究。
- 部分结局证据等级为低或中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dexmedetomidine is used as a local-anesthetics adjuvant in caudal block to prolong analgesia in pediatric infra-umbilical surgery. OBJECTIVE: We evaluated the analgesic efficacy and safety of the addition of caudal dexmedetomidine to local anesthetics (vs local anesthetics alone) in pediatric infra-umbilical surgery. EVIDENCE REVIEW: We searched 10 databases for randomized controlled trials (RCTs) of pediatric patients undergoing infra-umbilical surgery, comparing caudal block with and without dexmedetomidine as local anesthetic adjuvant. We performed a frequentist random-effects meta-analysis (R statistical package). We analyzed continuous outcomes as a ratio of means (ROM) and dichotomous data as relative risk (RR), along with 95% CI. We included 19 RCTs (n=1190 pediatric patients) in the meta-analysis. The primary outcome was duration of analgesia (defined as 'the time from caudal injection to the time at which the study-specific pain score was greater than a cut-off threshold'). FINDINGS: Data from 19 included RCTs (n=1190) suggested that compared with control (mean duration 346 min), the addition of caudal dexmedetomidine significantly prolonged the duration of analgesia (ratio of means 2.14, 95% CI 1.83 to 2.49, p<0.001; 'moderate' evidence). Trial-sequential analysis showed adequate 'information size' for the primary outcome. Caudal dexmedetomidine also reduced the number of analgesic administrations ('low' evidence), total acetaminophen dose ('moderate' evidence) and the risk of emergence delirium ('moderate' evidence). There were no significant differences in adverse effects such as hypotension, bradycardia, post-operative nausea and vomiting, urinary retention and respiratory depression. CONCLUSIONS: Our results suggest that the addition of dexmedetomidine to local anesthetic in caudal block significantly improves the duration of analgesia and reduces the analgesic requirements, while maintaining a similar risk-profile compared with local anesthetic alone. Further data on neurological safety are needed.
引用
- Shah UJ, Nguyen D, Karuppiaah N, et al. Efficacy and safety of caudal dexmedetomidine in pediatric infra-umbilical surgery: a meta-analysis and trial-sequential analysis of randomized controlled trials. Reg Anesth Pain Med. 2021. PMID: 33452203. doi:10.1136/rapm-2020-102024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。